Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | ||
Founding Date | Founding Date 2013 | Founding Date 2003 |
Type | Type Private | Type Subsidiary |
Tags | ||
Locations | Locations København, DK HQ | Locations Bundoora, AU HQ München, DE Hummelstown, US |
Employees | Employees 7 | Employees 20 |

vivoPharm is a company that provides preclinical oncology and immuno-oncology services.
View company